Targeting PKMYT1 Kinase as a Therapeutic Strategy for Treatment of Triple Negative Breast Cancer with Low Molecular Weight Cyclin E (LMW-E) Expression

被引：0
|
作者：
Li, Mi
Lulla, Amriti
Karakas, Cansu
Tsavaschidis, Spiridon
Wang, Yan
Nguyun, Tuyen
Bui, Tuyen
Marshall, Gary
Hunt, Kelly
Keyomarsi, Khandan
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PO1-16-04
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO1-16-04
引用
收藏
页数：2
相关论文
共 50 条
  • [21] A novel therapeutic strategy for triple-negative breast cancer targeting hERO1-Lα
    Wada, Asaka
    Kutomi, Goro
    Hirohashi, Yoshihiko
    Shima, Hiroaki
    Satomi, Fukino
    Kuga, Yoko
    Torigoe, Toshihiko
    Takemasa, Ichiro
    CANCER SCIENCE, 2022, 113 : 1051 - 1051
  • [22] Development of a novel treatment based on PKMYT1 inhibition for cisplatin-resistant bladder cancer with miR-424-5p-dependent cyclin E1 amplification
    Fukumoto, Wataru
    Okamura, Shunsuke
    Tamai, Motoki
    Arima, Junya
    Kawahara, Ichiro
    Fukuda, Ikumi
    Mitsuke, Akihiko
    Sakaguchi, Takashi
    Sugita, Satoshi
    Matsushita, Ryosuke
    Tatarano, Shuichi
    Yamada, Yasutoshi
    Nakagawa, Masayuki
    Enokida, Hideki
    Yoshino, Hirofumi
    BMC CANCER, 2024, 24 (01)
  • [23] Identification of New Substrates for Breast Tumor Specific Low-Molecular-Weight Cyclin E Cyclin-Dependent-Kinase 2.
    Akli, S.
    Duong, M.
    Keyomarsi, K. M. D.
    CANCER RESEARCH, 2011, 71
  • [24] Cdk2 is Required for Breast Cancer Mediated by the Low-Molecular-Weight Isoform of Cyclin E
    Akli, Said
    Van Pelt, Carolyn S.
    Bui, Tuyen
    Meijer, Laurent
    Keyomarsi, Khandan
    CANCER RESEARCH, 2011, 71 (09) : 3377 - 3386
  • [25] Inhibition of cyclin dependent kinase 9 by dinaciclib suppresses cyclin B1 expression and tumor growth in triple negative breast cancer
    Rajput, Sandeep
    Khera, Nimmish
    Guo, Zhanfang
    Hoog, Jeremy
    Li, Shunqiang
    Ma, Cynthia X.
    ONCOTARGET, 2016, 7 (35) : 56864 - 56875
  • [26] Low molecular weight cyclin E deregulates DNA replication and damage repair to promote genomic instability in breast cancer
    Li, Mi
    Tsavachidis, Spiridon
    Wang, Fuchenchu
    Bui, Tuyen
    Nguyen, Tuyen D.
    Luo, Linjie
    Multani, Asha S.
    Bondy, Melissa L.
    Hunt, Kelly K.
    Keyomarsi, Khandan
    CANCER RESEARCH, 2023, 83 (07)
  • [27] Low molecular weight cyclin E regulates response to aromatase inhibitors in post-menopausal breast cancer patients
    Doostan, Iman
    Moulder, Stacy L.
    Hunt, Kelly K.
    Keyomarsi, Khandan
    CANCER RESEARCH, 2015, 75
  • [28] Expression of low molecular weight isoforms (LMW) of cyclin E in human renal clear cell carcinoma (RCCC): possible associations with thyroid hormone receptors (TR)
    Nauman, A
    Poplawski, P
    Turowska, O
    Tanski, Z
    Pietrzak, M
    Puzianowska-Kuznicka, M
    FEBS JOURNAL, 2005, 272 : 487 - 488
  • [29] Targeting Replicative Stress and DNA Repair by Combining PARP and Wee1 Kinase Inhibitors Is Synergistic in Triple Negative Breast Cancers with Cyclin E or BRCA1 Alteration
    Chen, Xian
    Yang, Dong
    Carey, Jason P. W.
    Karakas, Cansu
    Albarracin, Constance
    Sahin, Aysegul A.
    Arun, Banu K.
    Guray Durak, Merih
    Li, Mi
    Kohansal, Mehrnoosh
    Bui, Tuyen N.
    Ha, Min-Jin
    Hunt, Kelly K.
    Keyomarsi, Khandan
    CANCERS, 2021, 13 (07)
  • [30] Expression of cyclin A, cyclin B1, and high molecular weight cytokeratin (34-beta-E12) in prostatic cancer
    不详
    VIRCHOWS ARCHIV, 2005, 447 (02) : 454 - 454
12345